← Compare landing
Adragos Pharma vs Delpharm
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Adragos Pharma | Delpharm |
|---|---|---|
| Summary | Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan. | Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/adragos-pharma/delpharm.md